Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

IBSQUtrition: microbiota associated with IBS symptom severity

ABSTRACT: Fecal Microbiota and SCFA signatures are not consistently related to Symptom Severity in Irritable Bowel Syndrome: A longitudinal study

PROVIDER: PRJEB44533 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR10317700_1.fastq.gz	Fastqsanger.gz
	ERR10317700_2.fastq.gz	Fastqsanger.gz
	ERR10317800_1.fastq.gz	Fastqsanger.gz
	ERR10317800_2.fastq.gz	Fastqsanger.gz
	ERR10317701_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 408

Similar Datasets

IBSQUtrition:microbiota associated with IBS symptom severity

Project description:Fecal Microbiota and SCFA signatures are not consistently related to Symptom Severity in Irritable Bowel Syndrome: A longitudinal study

| PRJEB44519 | ENA

IBSQUtrition: microbiota associated with IBS symptom severity

Project description:Fecal Microbiota and SCFA signatures are not consistently related to Symptom Severity in Irritable Bowel Syndrome: A longitudinal study

| PRJEB44518 | ENA

IBSQUtrition:microbiota associated with IBS symptom severity

Project description:Fecal Microbiota and SCFA signatures are not consistently related to Symptom Severity in Irritable Bowel Syndrome: A longitudinal study

| PRJEB44520 | ENA

IBSQUtrition:microbiota associated with IBS symptom severity

Project description:Fecal Microbiota and SCFA signatures are not consistently related to Symptom Severity in Irritable Bowel Syndrome: A longitudinal study

| PRJEB44515 | ENA

Transcription profiling of human IBS patients before and after treatment

Project description:Increased numbers of mast cells and their products have been linked to symptom onset and severity in patients with chronic diarrhea and abdominal pain. Although mast-cell inhibition ameliorates clinical manifestations and reduces mucosal inflammation, underlying molecular mechanisms remain unknown. Experiment Overall Design: Diarrhea-irritable bowel syndrome (d-IBS) patients were studied at baseline, or 6 months after natural evolution (control) or oral cromoglycate treatment. Jejunal biopsies were subjected to chip analysis (Affymetrix Human Genome U133 Plus 2.0 GeneChips).

2009-02-21 | E-GEOD-14842 | biostudies-arrayexpress

IBS symptom severity, diet and gut microbiota metabolism

Project description:Diet and gut microbiome interactions of relevance for symptoms in irritable bowel syndrome

| PRJEB34992 | ENA

RNA transcriptomics of healthy and PI-IBS colonic biopsies

Project description:A subset of post-infection irritable bowel syndrome (PI-IBS) patients have elevated, or high fecal proteolytic activity (PA). Fecal PA has been shown to correlate with increased symptom severity as well as lower quality of life scores, increased fecal output and increased intestinal permeability. To address the underlying mechanisms of barrier disruption as a consequence of high fecal PA, colonic biopsies were collected from healthy individuals PI-IBS patients (n=11). Individuals diagnosed with PI-IBS were further divided in to 2 subgroups, high PA and low PA as defined by the PA in matched fecal samples. RNA was extracted from the biopsies for bulk RNA sequencing to understand transcriptional differences between healthy and high PA PI-IBS patients as well as high PA and Low PA PI-IBS patients.

2021-12-31 | GSE168759 | GEO

GNPS IBD Severity

Project description:A collection of fecal sample LC-MS/MS data from patients with varied degrees of Irritable Bowel Syndrome severity.

2018-06-01 | MSV000082431 | GNPS

Control (IBS) & Ulcerative colitis (UC) subjects

Project description:IBS: Patients who have undergone a diagnostic program for gastrointestinal symptoms and where the diagnosis irritable bowel syndrome was reached. UC: Patients with well-diagnosed ulcerative colitis Keywords: other

2005-04-01 | GSE2461 | GEO

Small intestinal mucosal transcriptomics in IBS

Project description:Irritable bowel syndrome (IBS) patients often experience meal associated symptoms. Our objective was to determine small intestinal mechanisms of lipid-induced symptoms and rectal hypersensitivity in IBS based on RNA-seq.

2022-02-28 | GSE166869 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data